Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas: A clinicopathologic analysis of six cases

M. Paulli, R. Rosso, S. Kindl, E. Boveri, E. Bonoldi, V. Stracca, T. Motta, G. Arrigoni, M. Lazzarino, F. Menestrina, U. Magrini

Research output: Contribution to journalArticlepeer-review


Background. The CD30/Ki-1 antigen characterizes a series of non-Hodgkin's lymphomas (NHL) predominantly showing anaplastic large cell (ALCL) morphology and frequently involving the skin and other extranodal sites. In cutaneous large cell lymphomas, the CD30 expression was indicated as a favorable prognostic marker independently from cytology, anaplastic versus nonanaplastic. The stomach is the most common site of extranodal lymphomas in the adult population, but primary gastric CD30+ lymphomas have been reported rarely. Methods. The clinical, morphologic, and immunohistochemical features of six cases with primary CD30/Ki-1+ gastric large cell lymphomas were analyzed. Results. The mean age of patients was 64 years with a prevalence of women (M:F ratio = 1:2). Patients were assigned to Stage IE or IIE. Three of them died of disease, whereas the others are still alive (mean follow-up, 18 months). Three of six cases had ALCL morphology, whereas other cases had centroblastic, immunoblastic, and high-grade mucosa-associated lymphoid tissue lymphoma. Immunohistochemistry revealed a B-cell phenotype in three of six cases: a T-cell phenotype in one of six cases; and a null, non-B, non-T phenotype in two of six cases.

Original languageEnglish
Pages (from-to)541-549
Number of pages9
Issue number3
Publication statusPublished - 1994


  • CD30 antigen
  • extranodal lymphoma
  • gastric lymphoma
  • immunohistochemistry

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Primary gastric CD30 (Ki-1)-positive large cell non-Hodgkin's lymphomas: A clinicopathologic analysis of six cases'. Together they form a unique fingerprint.

Cite this